Browsing by Author "Azamor, Tamiris"
Now showing items 1-20 of 24
-
Activation of an effective immune response after yellow fever vaccination is associated with the genetic background and early response of IFN-γ and CLEC5A
Azamor, Tamiris et al. | Date Issued: 2021 -
Apoptosis characterization in mononuclear blood leukocytes of HIV patients during dengue acute disease
Torrentes-Carvalho, Amanda et al. | Date Issued: 2020 -
Association between maternal non-coding interferon-λ polymorphisms and congenital Zika syndrome in a cohort from brazilian northeast
Rossi, Átila Duque et al. | Date Issued: 2021 -
Auto-antibodies to type I IFNs can underlie adverse reactions to yellow fever live attenuated vaccine
Bastard, Paul et al. | Date Issued: 2021A vacina viva atenuada do vírus da febre amarela (YFV) pode, em casos raros, causar doença com risco de vida, geralmente em pacientes sem história prévia de doença viral grave. A deficiência completa de IFNAR1 autossômica ... -
Avaliação da expressão gênica de citocinas e polimorfismo da IL-28B em voluntários sadios após administração de IFNα peguilhado
Silva, Andréa M. V. da et al. | Date Issued: 2014 -
Biotechnological Evolution of siRNA Molecules: From Bench Tool to the Refined Drug
Cunha, Danielle de Brito e et al. | Date Issued: 2022 -
Cellular and Molecular Immunology Approaches for the Development of Immunotherapies against the New Coronavirus (SARS-CoV-2): Challenges to Near-Future Breakthroughs
Melgaço, Juliana Gil et al. | Date Issued: 2020A síndrome respiratória aguda grave causada pelo novo coronavírus (SARS-CoV-2), denominado COVID-19, foi destacada como a doença infecciosa mais importante do nosso tempo, sem vacina e sem tratamento disponível até o ... -
CLEC5A expression can be triggered by spike glycoprotein and may be a potential target for COVID-19 therapy
Machado, Thiago Lazari et al. | Date Issued: 2023 -
Congenital Zika syndrome is associated with interferon alfa receptor 1
Azamor, Tamiris et al. | Date Issued: 2021 -
Decidual production of interferon lambda in response to ZIKV persistence: clinical evidence and in vitro modelling
Azamor, Tamiris et al. | Date Issued: 2024 -
Development and validation of multiplex for measurement of antibodies against C. diphteriae, C. tetani and H. influenzae tipe B
Azamor, Tamiris et al. | Date Issued: 2013 -
Development and validation of multiplex test for measurement of antibodies against heptavalent vaccine componentes
Azamor, Tamiris et al. | Date Issued: 2014 -
Development of an alternative method for quantification of neutralizing antibody against yellow fever virus
Silva, Andrea M. V. da et al. | Date Issued: 2015 -
Evaluation of Two Adjuvant Formulations for an Inactivated Yellow Fever 17DD Vaccine Candidate in Mice
Cajaraville, Ana Carolina dos Reis Albuquerque et al. | Date Issued: 2023 -
Host-genetic combination based on IFNL3/IFNL4 polymorphism with other prognostic variables increases sustained response in antiviral therapy with pegylated interferon alpha
Silva, Andréa M. V. da et al. | Date Issued: 2019 -
Impairment of CD4+ T and Memory B Cell Responses but Normal Memory CD8+T-Cell Activation on Crohn’s Disease after COVID-19 Vaccination: A Twin Case
Melgaço, Fabiana Gil et al. | Date Issued: 2021 -
Interferon-lambda 3 and 4 polymorphisms increase sustained virological responses and regulate innate immunity in antiviral therapy with pegylated interferon-alpha
Silva, Andréa Marques Vieira da et al. | Date Issued: 2021 -
Plaque Reduction Neutralization Test (PRNT) Accuracy in Evaluating Humoral Immune Response to SARS-CoV-2
Horbach, Ingrid Siciliano et al. | Date Issued: 2024 -
Protective immunity after COVID-19 has been questioned: what can we do without SARS-CoV-2-IgG detection?
Melgaço, Juliana Gil et al. | Date Issued: 2020 -
Protective immunity after COVID-19 has been questioned: What can we do without SARS-CoV-2-IgG detection?
Melgaço, Juliana Gil et al. | Date Issued: 2020O coronavírus 2 da síndrome respiratória aguda grave (SARS-CoV-2) induz uma síndrome respiratória aguda grave chamada COVID-19. As manifestações clínicas do COVID-19 incluem diarreia, pneumonia, linfopenia, linfócitos ...